0001209191-15-078124.txt : 20151103 0001209191-15-078124.hdr.sgml : 20151103 20151103165801 ACCESSION NUMBER: 0001209191-15-078124 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20151026 FILED AS OF DATE: 20151103 DATE AS OF CHANGE: 20151103 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIND Therapeutics, Inc CENTRAL INDEX KEY: 0001385228 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 325 VASSAR STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6174913400 MAIL ADDRESS: STREET 1: 325 VASSAR STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: BIND Biosciences, Inc DATE OF NAME CHANGE: 20130130 FORMER COMPANY: FORMER CONFORMED NAME: BIND Biosciences Inc DATE OF NAME CHANGE: 20070105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TROIANO GREGORY CENTRAL INDEX KEY: 0001656781 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36072 FILM NUMBER: 151194390 MAIL ADDRESS: STREET 1: C/O BIND THERAPEUTICS, INC. STREET 2: 325 VASSAR STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2015-10-26 0 0001385228 BIND Therapeutics, Inc BIND 0001656781 TROIANO GREGORY C/O BIND THERAPEUTICS, INC. 325 VASSAR STREET CAMBRIDGE MA 02139 0 1 0 0 SENIOR VICE PRESIDENT Common Stock 5343 D Employee Stock Option (Right to Buy) 1.21 2019-05-04 Common Stock 2226 D Employee Stock Option (Right to Buy) 1.21 2020-02-18 Common Stock 1526 D Employee Stock Option (Right to Buy) 1.63 2021-04-25 Common Stock 6488 D Employee Stock Option (Right to Buy) 2.52 2022-04-23 Common Stock 3005 D Employee Stock Option (Right to Buy) 2.78 2023-04-22 Common Stock 2522 D Employee Stock Option (Right to Buy) 13.58 2024-03-02 Common Stock 8710 D Employee Stock Option (Right to Buy) 5.96 2025-03-05 Common Stock 13000 D Beginning on May 5, 2009, the option vests 25% after one year and in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date. The number of shares underlying the stock option granted to the Reporting Person was 3,816. The Reporting Person has exercised his option to purchase 1,590 of such shares. Beginning on February 19, 2010, the option vests 25% after one year and in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date. Beginning on April 26, 2011, the option vests 25% after one year and in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date. Beginning on April 24, 2012, the option vests 25% after one year and in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date. Beginning on April 26, 2013, the option vests 25% after one year and in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date. Beginning on March 3, 2014, the option vests 25% after one year and in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date. Beginning on March 6, 2015, the option vests 25% after one year and in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date. Exhibit List: Exhibit 24.1 - Power of Attorney /s/ Andrew Hirsch, Attorney-in-Fact for Gregory Troiano 2015-11-03 EX-24.3_612630 2 poa.txt POA DOCUMENT POWER OF ATTORNEY Gregory Troiano With respect to holdings of and transactions in securities issued by BIND Therapeutics, Inc. (the "Company"), the undersigned hereby constitutes and appoints the individuals named on Schedule A attached hereto, as may be amended from time to time, or any of them signing singly, with full power of substitution and resubstitution, to act as the undersigned's true and lawful attorney-in-fact to: 1. prepare, execute in the undersigned's name and on the undersigned's behalf, and submit to the United States Securities and Exchange Commission (the "SEC") a Form ID, including amendments thereto, and any other documents necessary or appropriate to obtain and/or regenerate codes and passwords enabling the undersigned to make electronic filings with the SEC of reports required by Section 16(a) of the Securities Exchange Act of 1934, as amended, or any rule or regulation of the SEC; 2. execute for and on behalf of the undersigned, Forms 3, 4, and 5 in accordance with Section 16 of the Securities Exchange Act of 1934, as amended, and the rules thereunder; 3. do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5, complete and execute any amendment or amendments thereto, and timely file such form with the SEC and any stock exchange or similar authority; and 4. take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney in fact may approve in his or her discretion. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution and resubstitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorneys-in-fact substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is any Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934, as amended. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 26 day of October, 2015. /s/ Gregory Troiano Gregory Troiano Schedule A Individuals Appointed as Attorney-in-Fact with Full Power of Substitution and Resubstitution 1. Andrew Hirsch 2. Christopher M. Lindblom